C. Carpenter

D. Vlahov, S. Holmberg, H. Farzadegan, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA

A. Caliendo, T. Flanigan, K. Mayer, 2000, AIDS.

Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).

K. Tashima, T. Flanigan, L. Bausserman, 1999, Journal of acquired immune deficiency syndromes.

HIV in couples in South India; implications for prevention

T. Flanigan, K. Mayer, M. Rogers, 2005, International journal of STD & AIDS.

Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.

T. Flanigan, K. Mayer, S. Solomon, 2005, Journal of acquired immune deficiency syndromes.

Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.

K. Mayer, K. Venkatesh, C. Carpenter, 2012, Health affairs.

Fusion inhibition--a major but costly step forward in the treatment of HIV-1.

K. Tashima, C. Carpenter, 2003, The New England journal of medicine.

Monitoring HIV treatment in the developing world.

T. Flanigan, K. Mayer, S. Solomon, 2002, The Lancet. Infectious diseases.

Molecular epidemiology of HIV-1 infection in the Philippines, 1985 to 1997: transmission of subtypes B and E and potential emergence of subtypes C and F.

M. Santiago, T. Flanigan, A. D. De Groot, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: a 3.5-year study.

K. Tashima, L. Bausserman, M. Flynn, 2001 .

Racial Differences in Serum Lipids in HIV+ Women Treated with Protease Inhibitor Regimens

K. Tashima, L. Bausserman, C. Carpenter, 2004, HIV clinical trials.

Epidemiology of human T cell leukemia virus type I infection in East Sepik Province, Papua New Guinea.

M. Lederman, W. Saxinger, M. Alpers, 1987, The Journal of infectious diseases.

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Michael S Saag, Mauro Schechter, Paul A Volberding, 2002, JAMA.

Report of the NIH Panel To Define Principles of Therapy of HIV Infection*

B. Walker, R. Schooley, D. Richman, 1998, Annals of Internal Medicine.

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

S. Hammer, D. Katzenstein, R. Schooley, 1998, JAMA.

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.

S. Hammer, D. Katzenstein, R. Schooley, 1997, JAMA.

Antiretroviral Therapy for Adult HIV-lnfected Patients: Recommendations From a State-of-the-Art Conference

R. Schooley, J. Phair, M. Hirsch, 1993 .

Clinical and Immunologic Progression in HIV‐Infected US Women Before and After the Introduction of Highly Active Antiretroviral Therapy

Joseph W. Hogan, Kenneth H. Mayer, Christina Korkontzelou, 2003, Journal of acquired immune deficiency syndromes.

Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

Douglas D. Richman, Julio S. G. Montaner, Martin S. Hirsch, 1996 .

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

S. Hammer, D. Katzenstein, R. Schooley, 1996, JAMA.

Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource‐Constrained Countries

T. Flanigan, K. Mayer, S. Solomon, 2002, Journal of acquired immune deficiency syndromes.

Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface

D. Nixon, A. Caliendo, T. Flanigan, 2000, AIDS.

The management of the clinical complications of antiretroviral therapy.

C. Carpenter, M. Stenzel, Molly S. Stenzel, 2000, Infectious disease clinics of North America.

Misdiagnosis of HIV Infection by HIV-1 Plasma Viral Load Testing: A Case Series

T. Greenough, J. Rich, T. Flanigan, 1999, Annals of Internal Medicine.

Reasons for Modification of Generic Highly Active Antiretroviral Therapeutic Regimens Among Patients in Southern India

T. Flanigan, K. Mayer, S. Solomon, 2006, Journal of acquired immune deficiency syndromes.

Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge.

T. Flanigan, B. Debuono, J. Hoy, 1993, The American journal of medicine.

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

S. Hammer, D. Katzenstein, R. Schooley, 2004, JAMA.

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women

Ronald A. Cohen, Charles C. J. Carpenter, David D. Celentano, 2001, AIDS.

Plasmodium falciparum genetic diversity and ancestry for HIV-infected patients in the developing world.

T. Flanigan, K. Mayer, S. Solomon, 2002 .

Violence Among Women with or at Risk for HIV Infection

D. Vlahov, S. Holmberg, S. Zierler, 1998, AIDS and Behavior.

Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract.

J. Hogan, A. Caliendo, K. Mayer, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neurocognitive Changes in AIDS: Evolution of Treatment of HIV Infection

E. Kojic, C. Carpenter, 2009 .

Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort.

J. Hogan, B. Snyder, R. Klein, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women.

J. Rich, T. Flanigan, K. Mayer, 1996, The American journal of medicine.

Human Immunodeficiency Virus Infection in North American Women: Experience with 200 Cases and a Review of the Literature

M. Stein, K. Mayer, T. Fiore, 1991, Medicine.

Guidelines for antiretroviral therapy

C. Carpenter, 2004 .

The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).

K. Wood, S. Holmberg, J. Brooks, 2008, American journal of epidemiology.

The Changing Presentation of HIV Disease in Women in Rhode Island

M. Stein, T. Flanigan, K. Mayer, 1993 .

Should women with human immunodeficiency virus be delivered by cesarean?

S. Cu-Uvin, C. Carpenter, J. Star, 1999, Obstetrics and gynecology.

Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.

Anne S De Groot, William Martin, Kenneth H Mayer, 2004, Methods.

Hit HIV-1 hard, but only when necessary

Mark Harrington, Charles CJ Carpenter, C. Carpenter, 2000, The Lancet.

Factitious HIV syndrome in young women.

J. Rich, M. Mileno, T. Fiore, 2001, The AIDS reader.

Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence

A. Caliendo, T. Flanigan, J. Mitty, 2003, AIDS.

Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia

John S. K. Kauwe, Pragna Patel, Charles C. J. Carpenter, 2011, AIDS and Behavior.

Neurocognitive and psychological contributions to quality of life in HIV-1-infected women

R. Paul, R. Cohen, T. Flanigan, 2000, AIDS.

HIV-1 in the female genital tract and the effect of antiretroviral therapy.

A. Caliendo, T. Flanigan, K. Mayer, 1998, AIDS.

Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993–1999

S. Holmberg, L. Gardner, R. Klein, 2003, Journal of Urban Health.

It is time to implement routine, not risk-based, HIV testing.

J. Bartlett, C. del Rio, C. Beckwith, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us

J. Chmiel, K. Lichtenstein, K. Buchacz, 2012, Antiviral therapy.

Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort.

W. K. Henry, M. Budoff, J. Brooks, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV and infectious disease care in jails and prisons: breaking down the walls with the help of academic medicine.

J. Rich, C. Beckwith, L. Taylor, 2009, Transactions of the American Clinical and Climatological Association.

IAS-USA Board of Directors

R. Schooley, M. Hirsch, D. Richman, 2011 .

Advances in AIDS and HIV infection.

K. Mayer, C. Carpenter, 1988, Advances in internal medicine.

Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007.

J. Rich, T. Flanigan, S. Cu-Uvin, 2009, Medicine and health, Rhode Island.

Women and AIDS.

K. Mayer, C. Carpenter, 1992, Scientific American.

A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use.

J W Hogan, J. Hogan, K. Tashima, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India

T. Flanigan, K. Mayer, S. Solomon, 2007, AIDS care.

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.

S. Hammer, D. Katzenstein, R. Schooley, 1998, JAMA.

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

S. Hammer, D. Katzenstein, D. Richman, 1997, Journal of the American Medical Association (JAMA).

Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

S. Hammer, D. Katzenstein, R. Schooley, 1997 .

Killed Vaccines: Cholera, Typhoid, and Plague

R. Hornick, C. Carpenter, 2010 .

Initial antiretroviral regimens

C. Carpenter, 2002, BMJ : British Medical Journal.